Carriers of Alzheimer's genetic marker have greater difficulty harnessing past knowledge

by Baycrest Centre for Geriatric CareDr. Claude Alain, a senior author on the paper and senior scientist at Baycrest's Rotman Research Institute. Credit: Provided by Baycrest.Adults carrying

Updated on: April 23,2024

Carriers of Alzheimer's genetic marker have greater difficulty harnessing past knowledge

by Baycrest Centre for Geriatric CareDr. Claude Alain, a senior author on the paper and senior scientist at Baycrest's Rotman Research Institute. Credit: Provided by Baycrest.Adults carrying

Updated on:April 23,2024

Scientists reveal structures of neurotransmitter transporter

bySt. Jude Children's Research HospitalCorresponding author Chia-Hsueh Lee, Ph.D., co-first author Shabareesh Pidathala, Ph.D., and co-first author Yaxin Dai, Ph.D. with maps of neurotransmi

Updated on: January 12,2024

Scientists reveal structures of neurotransmitter transporter

bySt. Jude Children's Research HospitalCorresponding author Chia-Hsueh Lee, Ph.D., co-first author Shabareesh Pidathala, Ph.D., and co-first author Yaxin Dai, Ph.D. with maps of neurotransmi

Updated on:January 12,2024

Eli Lilly hopeful of Alzheimer's drug approval after promising results

Credit: Unsplash/CC0 Public DomainA second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal conf

Updated on: March 09,2024

Eli Lilly hopeful of Alzheimer's drug approval after promising results

Credit: Unsplash/CC0 Public DomainA second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal conf

Updated on:March 09,2024

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st

Updated on: June 24,2024

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st

Updated on:June 24,2024

Unexpected link found between 2 schizophrenia risk proteins

by Emily Caldwell,The Ohio State UniversityBehavioral alterations in MAP6−/−and Kv3.1−/−mice. Adult (3–6 months old) WT B6 (black bars), MAP6−/−(red bars), and Kv3.1−/−(g

Updated on: January 12,2024

Unexpected link found between 2 schizophrenia risk proteins

by Emily Caldwell,The Ohio State UniversityBehavioral alterations in MAP6−/−and Kv3.1−/−mice. Adult (3–6 months old) WT B6 (black bars), MAP6−/−(red bars), and Kv3.1−/−(g

Updated on:January 12,2024

Differences in blood biomarkers in people with genetic risk of Alzheimer's

by Ali Howard,University of GlasgowPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers at the University of Glasgow have conducted the largest study to date

Updated on: April 23,2024

Differences in blood biomarkers in people with genetic risk of Alzheimer's

by Ali Howard,University of GlasgowPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers at the University of Glasgow have conducted the largest study to date

Updated on:April 23,2024

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on: April 08,2024

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD

Updated on:April 08,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on: January 11,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on:January 11,2024

Neuromuscular training cuts onset of chemo-induced peripheral neuropathy

by Elana GotkineNeuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 inJAMA Internal Medicine.Fiona Streckm

Updated on: July 31,2024

Neuromuscular training cuts onset of chemo-induced peripheral neuropathy

by Elana GotkineNeuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 inJAMA Internal Medicine.Fiona Streckm

Updated on:July 31,2024

Can Mediterranean diet help people with MS preserve thinking skills?

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with multiple sclerosis (MS) who follow a Mediterranean diet may have a lower risk for problems with memory and thinking sk

Updated on: May 20,2024

Can Mediterranean diet help people with MS preserve thinking skills?

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with multiple sclerosis (MS) who follow a Mediterranean diet may have a lower risk for problems with memory and thinking sk

Updated on:May 20,2024

Aduhelm: Will Medicare cover the controversial Alzheimer's drug?

by Dennis Thompson(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial A

Updated on: March 26,2024

Aduhelm: Will Medicare cover the controversial Alzheimer's drug?

by Dennis Thompson(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial A

Updated on:March 26,2024

How a protein in your brain could protect against Alzheimer's disease

by Katie Willis,University of AlbertaCredit: CC0 Public DomainNew research has found that the most common version of a protein called CD33 plays a crucial role in regulating white blood cells in

Updated on: May 18,2024

How a protein in your brain could protect against Alzheimer's disease

by Katie Willis,University of AlbertaCredit: CC0 Public DomainNew research has found that the most common version of a protein called CD33 plays a crucial role in regulating white blood cells in

Updated on:May 18,2024